SEC Filings

SEC Filings

On April 20, 2020, Melinta Therapeutics announced that it successfully completed its financial restructuring and emerged from Chapter 11. In accordance with the pre-negotiated Chapter 11 plan of reorganization, Melinta is now privately owned by affiliates of Deerfield Management Company, L.P., a healthcare investment firm.

Filing date Description Form Filing Group View

Official notification to shareholders of matters to be brought to a vote ("Proxy")

DEF 14A
Proxy Filings
View HTML

Initial filing by director officer or owner of more than ten percent.

3
3,4,5
View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
View HTML

Annual report which provides a comprehensive overview of the company for the past year

10-K
Annual Filings
View HTML

Report of unscheduled material events or corporate event

8-K
Current Reports
View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
View HTML

Data provided by Kaleidoscope.

Melinta Therapeutics, Inc. ©2020 ALL RIGHTS RESERVED | Terms of Use